Studies have shown that, in pancreatic ductal adenocarcinoma, phosphorylation mediated by Polo-like kinase 1 (Plk1) can inhibit the nuclear translocation of NF-κB, thereby reducing PD-L1 expression (11). The gene discussed is NFKB1; the disease is pancreatic ductal adenocarcinoma.